Palisade Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Palisade Bio and other ETFs, options, and stocks.About PALI
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery.
CEOJ. D. Finley
CEOJ. D. Finley
Employees8
Employees8
HeadquartersCarlsbad, California
HeadquartersCarlsbad, California
Founded2011
Founded2011
Employees8
Employees8
PALI Key Statistics
Market cap283.11M
Market cap283.11M
Price-Earnings ratio-0.45
Price-Earnings ratio-0.45
Dividend yield—
Dividend yield—
Average volume4.14M
Average volume4.14M
High today$2.00
High today$2.00
Low today$1.73
Low today$1.73
Open price$1.78
Open price$1.78
Volume4.51M
Volume4.51M
52 Week high$3.30
52 Week high$3.30
52 Week low$0.53
52 Week low$0.53
Stock Snapshot
With a market cap of 283.11M, Palisade Bio(PALI) trades at $2.15. The stock has a price-to-earnings ratio of -0.45.
On 2025-12-10, Palisade Bio(PALI) stock traded between a low of $1.73 and a high of $2.00. Shares are currently priced at $2.15, which is +24.3% above the low and +7.8% below the high.
The Palisade Bio(PALI)'s current trading volume is 4.51M, compared to an average daily volume of 4.14M.
In the last year, Palisade Bio(PALI) shares hit a 52-week high of $3.30 and a 52-week low of $0.53.
In the last year, Palisade Bio(PALI) shares hit a 52-week high of $3.30 and a 52-week low of $0.53.
People also own
Based on the portfolios of people who own PALI. This list is generated using Robinhood data, and it’s not a recommendation.